Bispecific antigen binding molecules targeting OX40 and FAP Grant US-11780919-B2 United States of America 10 Oct 2023
IMPROVED PHARMACOKINETIC ASSAYS FOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS Application EP-4119944-A1 European Patent Office 18 Jan 2023
Multivalent and multispecific DR5-binding fusion proteins and methods of treating… Grant US-11117973-B2 United States of America 14 Sep 2021
P2X7 receptor binders and polypeptides comprising the same Grant US-10875918-B2 United States of America 29 Dec 2020
Non-immunogenic single domain antibodies Application US-10526397-B2 United States of America 07 Jan 2020
Multivalent and multispecific DR5-binding fusion proteins Grant US-10308720-B2 United States of America 04 Jun 2019
Universal fibronectin type III bottom-side binding domain libraries Application US-10253313-B2 United States of America 09 Apr 2019
IMPROVED PHARMACOKINETIC ASSAYS FOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS Application WO-2017220645-A1 World Intellectual Property Organisation (WIPO) 28 Dec 2017
PD1 AND/OR LAG3 BINDERS Application WO-2017087589-A3 World Intellectual Property Organisation (WIPO) 13 Jul 2017
IMPROVED TNF BINDERS Application WO-2017081320-A1 World Intellectual Property Organisation (WIPO) 18 May 2017
IMPROVED P2X7 RECEPTOR BINDERS AND POLYPEPTIDES COMPRISING THE SAME Application WO-2017081265-A1 World Intellectual Property Organisation (WIPO) 18 May 2017
Universal fibronectin type III bottom-side binding domain libraries Application US-9139825-B2 United States of America 22 Sep 2015
SINGLE DOMAIN ANTIBODY WITH C-TERMINAL MODIFICATION Application WO-2014043509-A3 World Intellectual Property Organisation (WIPO) 30 May 2014
ANTIGEN BINDING MOLECULE WITH TERMINAL MODIFICATIONS Application WO-2014043509-A2 World Intellectual Property Organisation (WIPO) 20 Mar 2014